On September 15, 2020, a World Trade Organization (“WTO”) panel found that the Trump Administration’s unilateral tariffs imposed on Chinese products violated WTO rules regarding nondiscrimination and import tariff rates...more
The Court found the disqualification of an offeror from a pharmaceutical procurement was in error based on a U.S. Customs and Boarder Protection (CBP) interpretation of the Trade Agreements Act of 1979 (TAA)....more
2/14/2020
/ Country of Origin ,
Customs and Border Protection ,
Department of Veterans Affairs ,
Federal Acquisition Regulations (FAR) ,
Imports ,
India ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Procurement Policies ,
Trade Agreements Act ,
WTO
On February 3, 2020, the Department of Commerce published a final rule that amends the regulations for countervailing duty investigations to allow the imposition of duties on countries that undervalue their currencies....more
On April 8, 2019, the United States Trade Representative (USTR) proposed imposing tariffs on $11.2 billion worth of products from the European Union (EU). ...more
Following U.S. Trade Representative’s Section 301 investigation, presidential order threatens tariff increases and restrictions on Chinese inbound investment.
Tariff rises of 25 percent proposed, including for aerospace,...more
3/26/2018
/ Antitrust Provisions ,
China ,
Foreign Acquisitions ,
Intellectual Property Protection ,
National Security ,
Section 301 ,
Tariffs ,
Technology Sector ,
Trump Administration ,
USTR ,
WTO
President Trump issued a memorandum (“Memorandum”) directing his Administration to take several actions related to the investigation by the Office of U.S. Trade Representative (“USTR”) into China’s acts, policies, and...more
Further to our alert published on November 13, 2017 regarding whether acts, policies, and practices (“APPs”) of China related to transfer of technology, intellectual property, and innovation are actionable under Section...more
As President Trump visits China, U.S. is investigating a longstanding issue in bilateral relationship—technology transfer/intellectual property requirements—that has potential implications for trade.
U.S. business and...more
11/13/2017
/ Acquisitions ,
Anti-Monopoly ,
Bilateral Agreements ,
China ,
Confidential Business Information (CBI) ,
Cross-Border Transactions ,
Cybersecurity ,
Exports ,
Foreign Investment ,
Imports ,
Intellectual Property Protection ,
Licensing Rules ,
Mergers ,
Popular ,
Public Comment ,
Section 301 ,
Semiconductors ,
Source Code ,
Trade Act of 1974 ,
Trade Deficit ,
Trade Policy ,
Trump Administration ,
Unfair or Deceptive Trade Practices ,
USTR ,
WTO
“We will follow two simple rules: buy American and hire American.” While world leaders are pondering what these words from President Trump’s Inaugural Address mean for international trade, a different question looms for U.S....more
In a development that may have important implications for companies selling products to the U.S. government, on December 7, 2016, the Court of International Trade (“CIT”) issued a decision holding that the assembly in the...more